Article Information
History
- July 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Samantha M Loi1,2,*,
- Dhamidhu Eratne1,2,3,4,
- Claire Cadwallader1,
- Parsa Ravanfar5,
- Carolyn Chadunow1,
- Lesley Vidaurre3,
- Sarah Farrand1,
- Wendy Kelso1,
- Anita MY Goh6,
- Rosie Watson3,
- Andrew Evans7,
- Mark Walterfang1,2,4 and
- Dennis Velakoulis1,2
- 1Neuropsychiatry, Royal Melbourne Hospital, 300 Grattan Street, Parkville Australia 3050
- 2Department of Psychiatry, University of Melbourne, Parkville 3052
- 3Walter and Elizabeth Hall Institute of Medical Research, Parkville 3052
- 4Florey Institute of Neuroscience and Mental Health, Parkville 3052
- 5Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Carlton South, VIC, Australia
- 6National Ageing Research Institute, and Department of Psychiatry, University of Melbourne, Parkville 3052
- 7Department of Medicine, Royal Melbourne Hospital, 300 Grattan Street, Parkville 3050
- ↵*Corresponding author; email: samantha.loi{at}unimelb.edu.au
Posted July 07, 2021.
Investigating the clinical utility of biomarkers and other novel tests in younger onset neurocognitive disorders: the BeYOND study, protocol for a longitudinal clinical study in a real-world setting
